Bristol-Myers Squibb and Pfizer Present Large Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Non-Valvular Atrial Fibrillation
Page (1) of 1 - 03/17/17||
(March 17, 2017)
This article is no longer available,but here are some related topics.
HTN - Health Technology Net
DMN Newswire Newsletter
Source:Copyright (c) Business Wire..
All Rights Reserved